IN vitro cell-mediated immune reactions in herpes zoster patients treated with cimetidine.
Asian Pac J Allergy Immunol
;
1994 Jun; 12(1): 51-8
Artículo
en Inglés
| IMSEAR
| ID: sea-37179
ABSTRACT
In a double-blind placebo-control study the immunomodulating effect of cimetidine treatment for one week and placebo was investigated for cell-mediated immune reactions of 22 patients with herpes zoster (HZ). The mitogen induced leukocyte migration inhibition test (LMIT) and the in vitro proliferation of the patients' lymphocytes to exogenous IL-2 were used. Before any treatment, the mitogen induced leukocyte migration inhibition capacity (LMIC) of HZ patients was found to be significantly reduced (p < 0.02) as compared to healthy blood bank donors (controls). After one week, within the same treatment, the LMIC was significantly improved (p < 0.01). The patients' lymphoproliferative response to IL-2, before any treatment, was not significantly different from that of controls (p < 0.05). However, significantly higher values (p < 0.001) were found in patients tested 7 days after the disease onset as compared to those tested after 12 days. One-week cimetidine treatment significantly improved (p < 0.05) the lymphoproliferative response to IL-2 of initially low responders and had no effect on higher responder patients. In contrast to this, after one week of placebo treatment, a significant decrease in the patients' lymphoproliferative response to IL-2 could be observed as compared to patients' initial responses (p < 0.05) or to those of controls (p < 0.05). Although the number of cases is very small. The data suggest that after cimetidine treatment, as compared to placebo, healing from skin rash and pain was achieved in a significantly shorter time (p < 0.01).
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Anciano de 80 o más Años
/
Anciano
/
Femenino
/
Humanos
/
Masculino
/
Inhibición de Migración Celular
/
Estudios de Casos y Controles
/
Método Doble Ciego
/
Interleucina-2
/
Cimetidina
Tipo de estudio:
Ensayo Clínico Controlado
/
Estudio observacional
Límite:
Aged80
Idioma:
Inglés
Revista:
Asian Pac J Allergy Immunol
Año:
1994
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS